BREAKFAST PROGRAM │ 7:00 am – 8:00 am

Don’t miss this opportunity to engage faculty and colleagues in a smaller group setting. Speakers will deliver didactic presentations on a hot topic and then take questions from the audience. Breakfast will be provided.

GENERAL SESSIONS │ 8:00 am – 11:45 am

Surgical Technology

  • Advances in Aphakic Lens Management (Scleral Fixation of In-the-Bag Luxated or Subluxated IOLs)
  • Intraoperative OCT: Where Do We Stand?
  • 3D Wide Angle Viewing Endoscopic Vitrectomy
  • Advancements in Mechanics in VR Surgery: Fluidics, Pumps, Cut Rate
  • Advancements in Visualization in VR Surgery
  • Abstract Presentations
  • Panel Discussion

Retinal Detachment Surgery

  • Temporal Keratoprothesis and Vitrectomy
  • Chandelier Illumination for Scleral Buckling
  • Management of Retinal Detachment in Pediatric Age
  • The Art and Science of YAG Vitreolysis
  • Retinal Detachment from Macular Hole
  • ILM Peeling During Retinal Detachment Surgery: Is It Necessary?
  • Abstract Presentations

Imaging

  • Artificial Intelligence in OCT Imaging
  • Artificial Intelligence and Choroidal Imaging
  • Angiogenic Biomarkers in Neovascular AMD
  • Volume Rendering OCT
  • How Optical Coherence Angiography Changes My Practice
  • Agreement Between OCT Angiography and FA/ICG in Neovascular AMD
  • Mac Tel 2: A Multimodal Imaging Journey
  • Multimodal Imaging in Dry AMD
  • Multimodal Imaging in Polypoidal Choriodovasculopathy
  • Comparison of Ultra Widefield Devices

LUNCH PROGRAM │ 12:00 pm – 1:00 pm

Don’t miss this opportunity to engage faculty and colleagues in a smaller group setting. Speakers will deliver didactic presentations on a hot topic and then take questions from the audience. Lunch will be provided.

GENERAL SESSIONS │ 1:15 pm – 6:30 pm

Imaging

  • Ultra-Widefield Imaging and Diabetic Retinopathy
  • Ultra-Widefield Imaging and Retinal Vein Occlusion
  • Adaptive Optics Imaging in a Retina Practice
  • Abstract Presentations
  • Panel Discussion

Age-related Macular Degeneration

  • Nonexudative AMD
  • Drusen Ooze: New Hypothesis for Geographic Atrophy Growth
  • Oil Spill Strategies For AMD
  • Prevention of Exudative AMD in High Risk Eyes
  • Geographic Atrophy Associated with AMD, Incidence and Factors Influencing Growth Rate
  • C3 Complement Inhibition for the Reduction of Growth in Geographic Atrophy
  • Impact of Genetics on AMD Conversion and Response
  • Gene Therapy for Dry AMD
  • Emerging Therapies on Dry AMD
  • Exudative AMD
  • Non-exudative Neovascular AMD: What Is It?
  • Nascent Type 3 Neovascularization in AMD
  • Real-World Anti-VEGF Treatment for AMD
  • Angiopoietin Pathway in Neovascular Diseases
  • Anti-VEGF/Anti-Angiopoietin-2 Bispecific Antibody RG7716 in Exudative AMD
  • Myopic Choroidal Neovascularization
  • A Comparison of Brolucizumab and Afibercept in Neovascular Age-related Macular Degeneration (nAMD): Important Subanalyses
  • Stem Cell/Gene Therapy for AMD
  • Emerging Therapies for Exudative AMD

Diabetic Vitrectomy

  • Intravitreal Anti-VEGF as an Adjunct to Vitrectomy Surgery for Diabetic Tractional Retinal Detachment
  • Vitrectomy for Diabetic Macular Edema
  • Intraoperative Swept-source Microscope-integrated Optical Coherence Tomography in Vitrectomy for Diabetic Retinopathy
  • All-probe Vitrectomy Dissection Techniques for Diabetic Tractional Retinal Detachments: Lift and Shave
  • 3D Surgery for Diabetic Surgery
  • Advanced Maneuvers in Proliferative Diabetic Surgery
  • Abstract Presentations